1 INTRODUCTION 18
1.1 OBJECTIVES OF THE STUDY 18
1.2 1.2 MARKET DEFINITION 18
1.3 MARKET SCOPE 19
1.3.1 MARKETS COVERED 19
1.3.2 YEARS CONSIDERED FOR THE STUDY 20
1.4 CURRENCY 20
1.5 LIMITATIONS 20

Download Free Sample Pages of this report

2 RESEARCH METHODOLOGY 21
2.1 RESEARCH DATA 21
2.1.1 SECONDARY DATA 22
2.1.1.1 Key data from secondary sources 22
2.1.2 PRIMARY DATA 23
2.1.2.1 Key data from primary sources 23
2.1.2.2 Key industry insights 24
2.2 MARKET SIZE ESTIMATION 25
2.2.1 BOTTOM-UP APPROACH 25
2.2.2 TOP-DOWN APPROACH 26
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 27
2.4 ASSUMPTIONS FOR THE STUDY 28

3 EXECUTIVE SUMMARY 29

4 PREMIUM INSIGHTS 32
4.1 CRISPR TECHNOLOGY: MARKET OVERVIEW 32
4.2 EUROPE: CRISPR TECHNOLOGY MARKET, BY END USER AND COUNTRY (2018) 33
4.3 CRISPR TECHNOLOGY MARKET, BY APPLICATIONS, 2018 34

5 MARKET OVERVIEW 35
5.1 INTRODUCTION 35
5.2 MARKET DYNAMICS 35
5.2.1 DRIVERS 36
5.2.1.1 Rising availability of government and private funding 36
5.2.1.2 Growing adoption of CRISPR 37
5.2.2 RESTRAINTS 37
5.2.2.1 Off-target activity and the presence of alternative technologies 37
5.2.3 OPPORTUNITIES 38
5.2.3.1 Emerging markets 38
5.2.4 CHALLENGES 39
5.2.4.1 Ethical issues 39
5.2.4.2 Lack of standardized regulations 39
5.2.4.3 Pending patent issues & results of clinical trials 40
5.2.4.4 High costs of using CRISPR 41
5.2.4.5 Dearth of trained professionals 41

6 CRISPR TECHNOLOGY MARKET, BY PRODUCT & SERVICE 42
6.1 INTRODUCTION 43
6.2 CRISPR PRODUCTS 44
6.2.1 GROWING R&D ACTIVITIES TO DRIVE MARKET GROWTH 44
6.2.2 CRISPR ENZYMES 45
6.2.2.1 Enzymes to account for the largest share of the CRISPR products market 45
6.2.3 CRISPR LIBRARIES 46
6.2.3.1 Growing interest of researchers in the development of novel therapies is driving the adoption of CRISPR libraries 46
6.2.4 CRISPR KITS 47
6.2.4.1 Growth in awareness and increase in research activities are key factors driving market growth 47
6.2.5 OTHER CRISPR PRODUCTS 47
6.3 CRISPR SERVICES 49
6.3.1 CRISPR SERVICES TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD 49
6.3.2 GRNA DESIGN & VECTOR CONSTRUCTION 50
6.3.2.1 gRNA design and vector construction segment to dominate the CRISPR services market during the forecast period 50
6.3.3 CELL LINE ENGINEERING 50
6.3.3.1 Cell line engineering to register the highest growth in the CRISPR services market during the forecast period 50
6.3.4 SCREENING SERVICES 51
6.3.4.1 CRISPR screening services are required for the genome-wide interrogation of gene function 51
6.3.5 OTHER CRISPR SERVICES 52

7 CRISPR TECHNOLOGY MARKET, BY APPLICATION 53
7.1 INTRODUCTION 54
7.2 BIOMEDICAL APPLICATIONS 54
7.2.1 ACCELERATED PROGRESS IN GENE THERAPY, DRUG DISCOVERY, AND DIAGNOSTICS WILL DRIVE THE CRISPR TECHNOLOGY MARKET 54
7.3 AGRICULTURAL APPLICATIONS 57
7.3.1 AGRICULTURAL ACCELERATORS SET UP IN THE US, EUROPE, AND APAC ARE HELPING WITH THE COMMERCIALIZATION OF NEW CROPS 57
?
7.4 INDUSTRIAL APPLICATIONS 59
7.4.1 START-UPS IN THE US HAVE BEEN TAKING ADVANTAGE OF THE CRISPR TECHNOLOGY FOR INDUSTRIAL APPLICATIONS 59
7.5 BIOLOGICAL RESEARCH 61
7.5.1 PROOF-OF-CONCEPT STUDIES HELP IN DEVELOPING NEW APPLICATIONS OF CRISPR THAT CAN BE COMMERCIALIZED 61

8 CRISPR TECHNOLOGY MARKET, BY END USER 64
8.1 INTRODUCTION 65
8.2 PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES 65
8.2.1 SUCCESS OF CLINICAL TRIALS WILL PLAY A KEY ROLE IN THE CRISPR TECHNOLOGY MARKET FOR PHARMA AND BIOPHARMA COMPANIES 65
8.3 BIOTECHNOLOGY COMPANIES 68
8.3.1 RISING INTEREST OF BIOAGRICULTURAL AND BIOINDUSTRIAL COMPANIES IN CRISPR TO SPUR MARKET GROWTH 68
8.4 ACADEMIC & RESEARCH INSTITUTES 70
8.4.1 RESEARCH FUNDING AND COLLABORATIONS WITH COMMERCIAL ORGANIZATIONS WILL DRIVE GROWTH OF THIS SEGMENT 70
8.5 CONTRACT RESEARCH ORGANIZATIONS 73
8.5.1 ADOPTION OF CRISPR TECHNOLOGY BY CONTRACT RESEARCH ORGANIZATIONS WILL BE KEY DRIVING FACTOR 73

9 CRISPR TECHNOLOGY MARKET, BY REGION 76
9.1 INTRODUCTION 77
9.2 NORTH AMERICA 78
9.2.1 US 82
9.2.1.1 Strong scientific and industrial base will ensure sustained growth in the years to come 82
9.2.2 CANADA 84
9.2.2.1 Changes in regulations will generate opportunities in the CRISPR technology market 84
9.3 EUROPE 87
9.3.1 UK AND IRELAND 91
9.3.1.1 High activity in the area of CRISPR and CRISPR-based research 91
9.3.2 GERMANY 93
9.3.2.1 Strong base of pharma companies will favor the growth of CRISPR 93
9.3.3 FRANCE 96
9.3.3.1 Growing support and funds for CRISPR research to support the French market 96
9.3.4 REST OF EUROPE 98
9.4 ASIA PACIFIC 101
9.4.1 CHINA 105
9.4.1.1 China to register the highest growth rate in the APAC CRISPR technology market during the forecast period 105
?
9.4.2 JAPAN 107
9.4.2.1 Growing collaborations between universities and pharma/biotech companies to drive market growth 107
9.4.3 SOUTH KOREA 109
9.4.3.1 Strong private investments in CRISPR technology applications is the major factor driving market growth in the country 109
9.4.4 REST OF APAC 112
9.5 REST OF THE WORLD 115

10 COMPETITIVE LANDSCAPE 118
10.1 MARKET OVERVIEW 118
10.2 MARKET RANKING ANALYSIS (2017) 119
10.3 COMPETITIVE SITUATION AND TRENDS 120
10.3.1 COLLABORATIONS, AGREEMENTS, AND PARTNERSHIPS 120
10.3.2 PRODUCT LAUNCHES AND APPROVALS 121
10.3.3 ACQUISITIONS 121
10.3.4 PATENT APPROVALS 122
10.3.5 OTHER DEVELOPMENTS 123

11 COMPANY PROFILES 124
(Business Overview, Products Offered, Recent Developments, MnM View)*
11.1 THERMO FISHER SCIENTIFIC 124
11.2 MERCK KGAA 127
11.3 GENSCRIPT 130
11.4 INTEGRATED DNA TECHNOLOGIES (IDT) 134
11.5 HORIZON DISCOVERY GROUP 136
11.6 AGILENT TECHNOLOGIES 140
11.7 CELLECTA, INC. 143
11.8 GENECOPOEIA, INC. 145
11.9 NEW ENGLAND BIOLABS 146
11.10 ORIGENE TECHNOLOGIES, INC. 148
11.11 SYNTHEGO CORPORATION 150
11.12 TOOLGEN, INC. 153
*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.
?

12 APPENDIX 156
12.1 DISCUSSION GUIDE 156
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 160
12.4 AVAILABLE CUSTOMIZATIONS 162
12.5 RELATED REPORTS 162
12.6 AUTHOR DETAILS 163